The upregulation of LINC01315 in this study was reversed by cell transfection of LINC01315 interference RNA, which significantly inhibited the main cellular processes of TNBC and was consistent with its function in colorectal carcinoma and papillary thyroid cancer, indicating the tumor enhancer role of LINC01315 in TNBC. This evidence concerns the gene LINC01315 and thyroid gland papillary carcinoma.